ADIPOQ and neoplasm: Adiponectin treatment of breast and colorectal cancer cell lines decreases the phosphorylation of PI3K and AKT while the phosphorylation is increased in lung and pancreas cell lines, leading in both cases to a suppression of tumor growth [55, 60, 68].